STING1 and neoplasm: In further support of this, treatment of STING KO B16F10 tumor-bearing STING-deficient mice with TAK-676 also resulted in a complete lack of antitumor activity similar to what was observed with WT B16F10 tumor-bearing Goldenticket mice (GRI −16%, P = 0.349; Fig. 5D).